| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effects of intensive glucose lowering in type 2 diabetes.
|
N Engl J Med
|
2008
|
47.90
|
|
2
|
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
|
N Engl J Med
|
2010
|
21.49
|
|
3
|
Telmisartan, ramipril, or both in patients at high risk for vascular events.
|
N Engl J Med
|
2008
|
19.76
|
|
4
|
Effects of combination lipid therapy in type 2 diabetes mellitus.
|
N Engl J Med
|
2010
|
16.40
|
|
5
|
Basal insulin and cardiovascular and other outcomes in dysglycemia.
|
N Engl J Med
|
2012
|
10.09
|
|
6
|
Irbesartan in patients with heart failure and preserved ejection fraction.
|
N Engl J Med
|
2008
|
9.62
|
|
7
|
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
|
Lancet
|
2010
|
8.17
|
|
8
|
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
|
N Engl J Med
|
2011
|
8.14
|
|
9
|
The uncertainty principle and industry-sponsored research.
|
Lancet
|
2000
|
7.75
|
|
10
|
Risk of myocardial infarction and stroke after acute infection or vaccination.
|
N Engl J Med
|
2004
|
7.62
|
|
11
|
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
|
Lancet
|
2008
|
7.05
|
|
12
|
Warfarin and aspirin in patients with heart failure and sinus rhythm.
|
N Engl J Med
|
2012
|
6.60
|
|
13
|
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
|
N Engl J Med
|
2012
|
6.16
|
|
14
|
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
|
N Engl J Med
|
2010
|
6.05
|
|
15
|
Does this patient have influenza?
|
JAMA
|
2005
|
4.53
|
|
16
|
Evidence of bias in estimates of influenza vaccine effectiveness in seniors.
|
Int J Epidemiol
|
2005
|
4.04
|
|
17
|
Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.
|
N Engl J Med
|
2003
|
3.49
|
|
18
|
Community-acquired pneumonia.
|
Lancet
|
1998
|
3.21
|
|
19
|
Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review.
|
Lancet Infect Dis
|
2009
|
2.97
|
|
20
|
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors.
|
Int J Epidemiol
|
2005
|
2.92
|
|
21
|
Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.
|
J Am Coll Cardiol
|
1999
|
2.75
|
|
22
|
Do we need to adjudicate major clinical events?
|
Clin Trials
|
2008
|
2.61
|
|
23
|
Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome.
|
Eur Heart J
|
2011
|
2.60
|
|
24
|
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season.
|
MMWR Morb Mortal Wkly Rep
|
2012
|
2.40
|
|
25
|
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials.
|
Am Heart J
|
2004
|
2.25
|
|
26
|
Association between influenza vaccination and reduced risk of brain infarction.
|
Stroke
|
2002
|
1.81
|
|
27
|
Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study.
|
J Infect Dis
|
2012
|
1.73
|
|
28
|
National seasonal influenza vaccination survey in Europe, 2008.
|
Euro Surveill
|
2008
|
1.63
|
|
29
|
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
|
J Am Coll Cardiol
|
2007
|
1.58
|
|
30
|
Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study.
|
CMAJ
|
2010
|
1.58
|
|
31
|
The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study.
|
Vaccine
|
2010
|
1.50
|
|
32
|
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
|
Am Heart J
|
2007
|
1.33
|
|
33
|
Association of influenza vaccination and reduced risk of recurrent myocardial infarction.
|
Circulation
|
2000
|
1.29
|
|
34
|
Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons.
|
Infection
|
2009
|
1.29
|
|
35
|
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
|
JAMA
|
2013
|
1.21
|
|
36
|
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.
|
Eur Heart J
|
2008
|
1.19
|
|
37
|
Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people.
|
BMJ
|
2004
|
1.19
|
|
38
|
The composition of coronary-artery plaques.
|
N Engl J Med
|
1997
|
1.15
|
|
39
|
Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study.
|
Eur Heart J
|
2004
|
1.14
|
|
40
|
Role of endothelial dysfunction in coronary artery disease and implications for therapy.
|
Am J Cardiol
|
1997
|
1.13
|
|
41
|
Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
|
Clin Trials
|
2009
|
1.10
|
|
42
|
Influenza virus infection and risk of acute myocardial infarction.
|
Inflammation
|
2008
|
1.07
|
|
43
|
Influenza vaccination and the risk of primary cardiac arrest.
|
Am J Epidemiol
|
2000
|
1.06
|
|
44
|
Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events.
|
Am J Epidemiol
|
2002
|
1.06
|
|
45
|
Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease.
|
Circulation
|
1997
|
1.05
|
|
46
|
Impact of influenza vaccination on major cause-specific mortality.
|
Vaccine
|
2006
|
1.04
|
|
47
|
Influenza vaccines for preventing coronary heart disease.
|
Cochrane Database Syst Rev
|
2008
|
1.02
|
|
48
|
Influenza vaccination and risk of incident myocardial infarction.
|
Hum Vaccin
|
2006
|
0.99
|
|
49
|
Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population.
|
J Am Coll Cardiol
|
2001
|
0.97
|
|
50
|
Elevated infection parameters and infection symptoms predict an acute coronary event.
|
Ther Adv Cardiovasc Dis
|
2008
|
0.87
|
|
51
|
Influenza vaccination and major adverse vascular events in high-risk patients.
|
Circulation
|
2012
|
0.86
|
|
52
|
Myocardial infarction vaccine? Evidence supporting the influenza vaccine for secondary prevention.
|
Eur Heart J
|
2011
|
0.83
|
|
53
|
Chlamydia pneumoniae-induced transactivation of the major immediate early promoter of cytomegalovirus: potential synergy of infectious agents in the pathogenesis of atherosclerosis.
|
J Infect Dis
|
2000
|
0.80
|
|
54
|
Vascular events responsible for thrombotic occlusion of a blood vessel.
|
Clin Cardiol
|
1993
|
0.75
|